Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2021Translational NeurodegenerationOpen Access

Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials

View Full Paper
Ask AI
Bookmark
Share

Authors

SWSimon WitzelValve (United States)FFFelix FrauhammerHeidelberg UniversityPSPetra SteinackerLuther University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Witzel et al. (2021) studied this question.

synapsesocial.com/papers/6a7612ed1ce449dc427088a6https://doi.org/10.1186/s40035-021-00257-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS2012 · 91 citations
  2. 2Environmental variability supports chimpanzee behavioural diversity2020 · 402 citations
  3. 3Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS2020 · 111 citations
  4. 4Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis2020 · 49 citations
  5. 5Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis2018 · 122 citations